IL6 and neoplasm: Concurrently, SASP reprograms cancer metabolism; IL-6-induced STAT3 activation shifts energy production toward glycolysis while suppressing oxidative phosphorylation (OXPHOS), thereby fueling rapid tumor growth (72).